Suchergebnisse
Bitfarms Q2 Earnings Call Highlights
Key Points
- Interested in Bitfarms Ltd.? Here are five stocks we like better.
- Second-quarter results deteriorated as revenue fell to $30 million from $61 million a year earlier, while the
SpaceX Stock Posts Best Weekly Gain: Should You Tap It Via ETFs?
SpaceX SPCX closed a key week in the green, with shares climbing about 26%, after the company reported its first earnings as a public company and completed the largest share unlock in its brief
EFC Q2 Earnings Call Sees High-40s ADE as Longbridge Scales
Ellington Financial Inc. EFC used its second-quarter earnings call to frame a higher earnings baseline, with management comfortable guiding adjusted distributable earnings into the high-40-cent
ARKO Q2 Earnings Call Centers on USPP Deal and Margin Defense
ARKO Corp. ARKO entered its Q2 2026 call with a split message: retail demand softened as elevated fuel prices pressured consumers, but management kept full-year adjusted EBITDA guidance intact and
ACMR Q2 Earnings Call Raises Revenue Floor as Orders Accelerate
ACM Research, Inc. ACMR used its Q2 2026 call to emphasize stronger orders, new-product commercialization and firmer full-year visibility. First-half orders rose 105% year over year, with greater
Is Labcorp Stock a Buy as Growth Improves but Valuation Stays Rich?
Labcorp Holdings Inc. LH is entering the second half of 2026 with faster revenue growth, wider margins and higher full-year guidance. Specialty testing and Biopharma Laboratory Services are adding
SKWD Q2 Earnings Beat Estimates as Premium Growth Accelerates
Skyward Specialty Insurance Group, Inc. SKWD delivered a solid second quarter of 2026, with operating earnings per share of $1.30, which increased 46.1% from the year-ago level and beat the Zacks
FOXA Television and Tubi Drive Q4 Earnings as Cable Faces Higher Costs
Fox Corporation FOXA reported fourth-quarter fiscal 2026 adjusted earnings of $1.79 per share, which beat the Zacks Consensus Estimate of $1.34 by 33.58% and increased 41% year over year from
Can Altria's Smoke-Free Push Finally Drive Long-Term Growth?
Altria Group, Inc.’s MO smoke-free strategy is increasingly centered on nicotine pouches, with on! PLUS emerging as a key part of that effort. In the second quarter of 2026, Helix expanded on! PLUS
Tripadvisor's Q2 Earnings and Revenues Miss Amid Macro Pressures
Tripadvisor TRIP shares have appreciated 3.5% since the company reported its second quarter 2026 results on Aug. 6. The move comes even as both revenues and earnings missed the Zacks Consensus
AMC's Europe Business Roars Back: Can International Growth Continue?
AMC Entertainment Holdings AMC delivered a standout second-quarter 2026 performance, with its European operations emerging as a key growth driver.
Attendance across Europe jumped 17.9% year over
Fiserv Cuts 2026 Outlook as Margin Pressure Tests Its Recovery Story
Fiserv, Inc. FISV reset investor expectations after second-quarter 2026 earnings and revenues missed the Zacks Consensus Estimate and management lowered its full-year outlook. The central question
MPC Jumps 18.1% in 3 Months as Refining Strength Builds Momentum
Marathon Petroleum Corporation MPC shares have gained 18.1% over the past three months, while the Zacks Consensus Estimate for current fiscal-year earnings has risen 41.6% in the past four weeks
Disney Beats on Parks & Streaming Growth in Q3: Buy or Hold the Stock?
Disney DIS delivered a third-quarter fiscal 2026 performance leaning on two durable engines, Experiences and streaming, even as shares have struggled to reflect that operating momentum. For the
Here's Why Replimune Stock Skyrockets Nearly 223% in 3 Months
Shares of Replimune Group REPL have surged nearly 223% over the past three months, as the company steadily advanced its lead oncolytic immunotherapy, RP1 (vusolimogene oderparepvec), toward
Eyeing Short-Term Opportunities? ETFs Worth a Look
Market volatility is far from over, as investors continue to navigate shifting risks, ranging from bouts of rising geopolitical tensions stemming from the Middle East conflict to persistent weakness
Is IMCR Worth Buying as Kimmtrak Growth Meets a Premium Valuation?
Immunocore Holdings plc IMCR offers a clear trade-off between commercial momentum and valuation risk. Kimmtrak continues to expand in metastatic uveal melanoma, while late-stage studies could open
IMCR Q2 Revenues Climb 18.3% as Kimmtrak Demand Helps Offset EPS Miss
Immunocore Holdings plc IMCR posted second-quarter 2026 revenues of $115.9 million, up 18.3% year over year and above the Zacks Consensus Estimate of $114 million. The company’s loss of 2 cents per
Gates Industrial Raises 2026 Outlook as Industrial Demand Strengthens
Gates Industrial Corporation Ltd. GTES raised its 2026 outlook after second-quarter 2026 results showed improving demand across a broad range of industrial markets. Higher core sales, improved
Is Gates Stock Worth Buying as Growth Improves but Risks Persist?
Gates Industrial Corporation Ltd. GTES entered the second half of 2026 with better operating momentum. The company's second-quarter core sales rose 4.9% year over year, and adjusted EBITDA margin


